Daundong, Perlyn .
HRN: 26-05-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/14/2024
10/21/2024
IV
4.5
Q8
T/c Cholangitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes